Dalantercept plus axitinib combination for advanced kidney cancer
The results from a recent phase II study comparing a [...]
The results from a recent phase II study comparing a [...]
The development of dalantercept, an anaplastic lymphoma kinase 1 (ALK1) [...]
Results from the first part of the phase 2 DART [...]